Predictive Oncology launched new AI platform for vaccine and drug development targeting coronaviruses and Acute Respiratory Syndromes
On Mar. 12, 2020, Predictive Oncology announced it will launch a new AI platform for vaccine and drug…
-
-
Mayo Clinic developed test to detect COVID-19 infection
On Mar. 12, 2020, the Mayo Clinic announced it had developed a test that can detect the SARS-CoV-2…
-
Pluristem and Charit’ University of Medicine Berlin joinly target potential treatment for respiratory and inflammatory Intratissue complications caused by COVID-19
On Mar. 12, 2020, Pluristem Therapeutics announced it a collaborative agreement with the BIH Center for Regenerative Therapy…
-
Vir Biotec announced intent to collaborate with Biogen on manufacturing of antibodies to potentially treat COVID-19
On Mar. 12, 2020, Vir Biotech announced it had signed a letter of intent with Biogen for the…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Non-Profit Research | Therapeutics
Emory University among U.S. sites to host clinical trial for COVID-19 treatment
On Mar. 12, 2020, Emory University announced it was participating in a National Institutes of Health (NIH) sponsored…
-
AbCellera and Eli Lilly to co-develop antibody therapies for treatment of COVID-19
On Mar. 12, 2020, AbCellera and Eli Lilly announced an agreement to co-develop antibody products for the treatment…
-
Innovation Pharma announced testing procedures of Brilacidin against Coronavirus
On Mar. 12, 2020, Innovation Pharma announced research procedures that one of the 12 Regional Biocontainment Labs (RBLs)…
-
Emergent BioSolutions initiated development of product candidates for treatment of Coronavirus
On Mar. 11, 2020, Emergent BioSolutions announced it has initiated development of two product candidates for treatment and…
-
La Jolla Institute for Immunology identified potential targets for immune responses to novel coronavirus
On Mar. 11, 2020, the La Jolla Institute for Immunology (LJI) and the J. Craig Venter Institute announced…
-
Bill & Melinda Gates Foundation, Wellcome, and Mastercard launched COVID-19 Therapeutics Accelerator
On Mar. 10, 2020, the Bill & Melinda Gates Foundation, Wellcome, and Mastercard committed up to $125 million…
-
CaroGen and Yale scientists joined to develop a COVID-19 vaccine
On Mar. 10, 2020, CaroGen and scientists from Yale announced they had begun work on a vaccine targeting…
-
U.S. Regional Biocontainment Lab to begin testing of Brilacidin against Coronavirus (COVID-19)
On Mar. 10, 2020, Innovation Pharma announced that management was advised that testing of Brilacidin, the Company’s flagship…
-
CerTest Biotec and BD announced COVID-19 diagnostic test
On Mar. 10, 2020, BCerTest Biotec, along with BD (Becton, Dickinson and Company) announced that the VIASURE SARS-CoV-2…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | NIH | Non-Profit Research | Therapeutics | U.S. Congress
Innovation Pharma Brilacidin received by US Regional Biocontainment Lab for testing against COVID-19
On Mar. 9, 2020, Innovation Pharmaceuticals announced it was notified by one of the 12 Regional Biocontainment Labs…
-
Ampligen to be tested by Japan’s National Institute of Infectious Diseases as potential treatment for SARS-CoV-2
On Mar. 9, 2020, AIM ImmunoTech announced that the National Institute of Infectious Diseases (NIID) in Japan will…
-
UTSW researchers and international collaborators found human protein that potently inhibits coronavirus
On Mar. 8, 2020, an international team of investigators reported finding a protein produced by the human immune…
-
University of British Columbia researchers received $2.8 million in federal funding to help with global COVID-19 response
On Mar. 6, 2020, University of British Columbia (UBC) researchers Yue Qian, Dr. Richard Lester, Dr. Srinivas Murthy,…
-
Innovation Pharma signs second MTA to explore Brilacidin as Coronavirus COVID-19 treatment
On Mar. 6, 2020, Innovation Pharmaceuticals continues to receive inquiries regarding the potential of Brilacidin, the Company’s novel…
-
German lab demonstrated feasibility to detect SARS-Coronavirus-2 using Hologic’s Panther Fusion System
On Mar. 5, 2020, Hologic announced a molecular assay for detecting the novel coronavirus SARS-CoV-2 (previously 2019-nCoV) on…
-
Quest Diagnostics planned launch for coronavirus disease 2019 (COVID-19) test
On Mar. 5, 2020, Quest Diagnostics announced it will launch a coronavirus (COVID-19) test service. The new test…
-
LabCorp launched test for Coronavirus (COVID-19)
On Mar. 5, 2020, LabCorp announced that it was making its LabCorp 2019 Novel Coronavirus (COVID-19), NAA test…
-
OPKO Health introduced Coronavirus disease (COVID-19) test
On Mar. 5, 2020, BioReference Laboratories, an OPKO Health company, announced it was offering a test for the…
-
Cocrystal Pharma announced plans to advance Coronavirus program
On Mar. 6, 2020, Cocrystal Pharma announced it had initiated its Coronavirus program. Cocrystal previously entered into a…
-
University of Washington Medicine deployed new test for coronavirus
On Mar. 4, 2020, the UW Medicine Clinical Virology Lab announced it had received U.S. Food and Drug…
-
Vir Biotec and Alnylam expanded collaboration to advance RNAi therapeutics for Treatment of Coronavirus Infection
On Mar. 4, 2020, Vir Biotech and Alnylam Pharmaceuticals announced an expansion of their existing collaboration to include…
-
Luminex provided updates on critical efforts related to novel Coronavirus
On Mar. 4, 2020, Luminex announced they were working on multiple solutions to augment their NxTAG and ARIES…
-
Heat Biologics launched program to develop vaccine to protect against COVID-19 coronavirus
On Mar. 3, 2020, Heat Biologics announced the Company has formally launched a program within its wholly-owned subsidiary,…
-
Mateon updated Rapid Antiviral Response Program Initially targeting COVID-19
On Mar. 2, 2020, Mateon Therapeutics reported the company had been evaluating its therapeutic and AI platforms to…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics | Vaccine | WHO
UN released $15 million to help vulnerable countries battle the spread of the coronavirus
On Mar. 1, 2020, the United Nations Humanitarian Chief Mark Lowcock released US$15 million from the Central Emergency…
-
Novavax advanced development of novel COVID-19 vaccine
On Feb. 26, 2020, Novavax announced progress in its efforts to develop a novel vaccine to protect against…
